SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001136261-10-000291
Filing Date
2010-11-02
Accepted
2010-11-02 16:06:01
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 s3body.htm S-3 177066
2 FORM OF INDENTURE RELATING TO SENIOR DEBT SECURITIES. exh4-2.htm EX-4.2 570910
3 FORM OF INDENTURE RELATING TO SUBORDINATED DEBT SECURITIES. exh4-3.htm EX-4.3 648351
4 OPINION exh5-1.htm EX-5.1 22513
5 STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES exh12-1.htm EX-12.1 33769
6 CONSENT exh23-1.htm EX-23.1 1049
7 S-3 form_s-3.pdf S-3 338654
8 OPINION exhibit5-1.pdf EX-5.1 109556
9 STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES exhibit12-1.pdf EX-12.1 22229
10 CONSENT exhibit23-1.pdf EX-23.1 9724
11 LOGO newlogo.jpg GRAPHIC 111746
  Complete submission text file 0001136261-10-000291.txt   2271358
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-170283 | Film No.: 101158329
SIC: 2836 Biological Products, (No Diagnostic Substances)